AFP and neoplasm: Comparative analysis of tumor markers and hematological parameters before and after neoadjuvant therapy demonstrated significant reductions in serum CEA and CA19-9 levels in both the NACI and NAC groups (P < 0.05), while AFP levels didn’t change significantly (P > 0.05).